Prescribing patterns of anti-asthma drugs in pediatric patients

Hai Lun Sun, Ko Huang Lue, Yea-Huei Kao

研究成果: Article同行評審

3 引文 斯高帕斯(Scopus)


Guidelines from the Global Initiative for Asthma (GINA) mention several medications for the treatment of asthma. These medications include oral and inhaled beta-2 agonists, oral and inhaled corticosteroids, xanthines, leukotriene receptor antagonists, and their combinations. In addition to asthma, these drugs are commonly prescribed to treat other respiratory diseases, such as acute bronchitis, chronic cough, lower respiratory infection, or even bronchopneumonia. We analyzed differences in prescribing patterns between pediatric patients with and those without asthma, as coded in the claim records from the National Health Insurance Research Database. Oral beta-2 agonists were the most frequently monotherapy in both groups of patients (52.6-77.6% vs 62.8-84. 8%). Oral beta-2 agonists combined with xanthines or oral corticosteroids combined with an oral beta-2 agonist were the most frequent combination therapies in both groups. Inhaled corticosteroids were used in 3.1-11.0% of patients with asthma; the rate varied by patient age. In conclusion, prescribing patterns were similar in pediatric patients with and those without asthma.

期刊Acta Paediatrica Taiwanica
出版狀態Published - 2005 7月 1

All Science Journal Classification (ASJC) codes

  • 兒科、圍產兒和兒童健康


深入研究「Prescribing patterns of anti-asthma drugs in pediatric patients」主題。共同形成了獨特的指紋。